Tenet Healthcare Corporation THC
Set alert
273.04 USD +4.15 +1.54%
As of Nov 3, 1:42 PM ET
265.26 Day range 275.42
161.37 52-week range 280.77
- YTD
- +37.40%
- 1 year
- +35.58%
- Open
- 266.82
- Prev close
- 268.89
- Mkt cap
- 21.74B
- Vol
- 569.65K
- Avg vol
- 752.10K
- EPS
- 33.74
- P/E
- 8.10
- Div yield
- 0.00%
More statistics
- Low
- 265.26
- High
- 275.42
- Forward P/E
- 13.10
- Beta
- 1.20
- Short ratio
- 2.63
- Inst. own
- 103.12%
- Dividend
- 0.00
- Ex-div date
- Mar 12, 2000
- Earnings
- Feb 10, 2027
- 50-d avg
- 264.87
- 200-d avg
- 220.21
- 1y target
- 298.82
6M chart
Events in this range
- Jul 22, 2026Earnings: 6.12; estimate 4.26; surprise 43.66%
- Sep 23, 2026Rating: BMO Capital · — → Market Perform
- Oct 16, 2026Rating: Guggenheim · Buy → Buy
- Oct 29, 2026Earnings: 6.64; estimate 4.68; surprise 41.88%
- Oct 30, 2026Rating: Guggenheim · Buy → Buy
- Nov 2, 2026Rating: Wells Fargo · Overweight → Overweight
- Nov 2, 2026Rating: RBC Capital · Outperform → Outperform
- Nov 2, 2026Rating: Leerink Partners · Outperform → Outperform
Signals (32)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 3, 2026 | 4 hours ago |
| MACD: Sell Signal | Nov 2, 2026 | 1 day ago |
| MACD: Buy Signal | Oct 30, 2026 | 4 days ago |
| SMA: Bullish | Oct 28, 2026 | 6 days ago |
| SMA: Bearish | Oct 27, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 27, 2026 | 1 week ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| RSI: Overbought | Aug 20, 2026 | 2 months ago |
| RSI: Overbought | Aug 18, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| RSI: Overbought | Aug 12, 2026 | 2 months ago |
| RSI: Overbought | Aug 7, 2026 | 2 months ago |
| RSI: Overbought | Aug 4, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 24, 2026 | 3 months ago |
| RSI: Overbought | Jul 24, 2026 | 3 months ago |
| SMA: Bullish | Jul 21, 2026 | 3 months ago |
Newest 20 of 32.
Financial health
Altman Z-Score
2.26 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
8 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A4 / 5 overall
- DCF 5
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 1
- P/E 4
- P/B 2
Valuation
P/E 12.7×
FY 2016 5y median 12.6× FY 2025
P/S 0.8×
FY 2016 5y median 0.4× FY 2025
P/B 4.2×
FY 2016 5y median 4.6× FY 2025
P/FCF 7.1×
FY 2016 5y median 9.6× FY 2025
EV/EBITDA 6.3×
FY 2016 5y median 6.3× FY 2025
EV/Sales 1.3×
FY 2016 5y median 1.1× FY 2025
FCF Yield 14.1%
FY 2016 5y median 10.4% FY 2025
Profitability
Gross Margin 82.3%
FY 2016 5y median 38.0% FY 2025
Operating Margin 16.1%
FY 2016 5y median 14.7% FY 2025
Net Margin 6.6%
FY 2016 5y median 4.7% FY 2025
ROE 33.3%
FY 2016 5y median 38.0% FY 2025
ROIC 11.5%
FY 2016 5y median 9.9% FY 2025
ROA 4.7%
FY 2016 5y median 3.3% FY 2025
Growth (YoY)
Revenue 3.1%
FY 2016 FY 2025
Operating Income -42.3%
FY 2016 FY 2025
EPS (diluted) -52.6%
FY 2016 FY 2025
Free Cash Flow 126.7%
FY 2016 FY 2025
Financial Health
Current Ratio 1.8×
FY 2016 5y median 1.5× FY 2025
Quick Ratio 1.7×
FY 2016 5y median 1.4× FY 2025
Debt / Equity 3.1×
FY 2016 5y median 9.3× FY 2025
Net Debt / EBITDA 2.3×
FY 2016 5y median 3.6× FY 2025
Interest Coverage 4.2×
FY 2016 5y median 3.1× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
